Sanofi (SAN) Stock Chart & Stock Price History €80.84 +1.17 (+1.47%) As of 08/7/2025 Add Compare Share Share Chart Stock AnalysisChartHeadlinesSustainabilityBuy This Stock Sanofi Stock Price Performance The Sanofi (SAN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 15.13%, with a year-to-date return of -13.21%. In the past month, the stock has decreased 1.94%, reflecting recent market activity. As of the latest close, Sanofi traded at €79.67 with a market cap of and volume of 2.75 million shares. Five years ago, the stock traded at €86.40, representing a 6.44% decrease over that period. At the time, it had a market cap of and a volume of 1.82 million shares. Receive SAN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.54%1 Month Performance-1.94%3 Month Performance-11.81%Year-To-Date Performance-13.21%1 Year Performance-15.13%5 Year Performance-6.44% SAN Stock Chart for Friday, August, 8, 2025 SAN Chart by TradingView Sanofi Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025€79.67€80.84+1.47%€81.04€78.791.81 million shs$0.0008/07/2025€82.03€79.67-2.88%€82.63€79.672.75 million shs$0.0008/06/2025€82.00€82.03+0.04%€83.02€82.031.52 million shs$0.0008/05/2025€80.34€82.00+2.07%€82.00€79.982.18 million shs$0.0008/04/2025€80.34€80.34€80.61€76.783.75 million shs$0.0008/01/2025€85.52€78.84-7.81%€84.93€78.385.41 million shs$0.0007/31/2025€85.85€85.52-0.38%€85.76€84.761.70 million shs$0.0007/30/2025€85.50€85.85+0.41%€86.28€84.871.40 million shs$0.0007/29/2025€85.11€85.50+0.46%€87.15€85.051.55 million shs$0.0007/28/2025€85.11€85.11€85.56€84.68906,901 shs$0.00 Get the Latest News and Ratings for SAN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025€84.65€85.22+0.67%€85.72€85.081.38 million shs$0.0007/24/2025€82.55€84.65+2.54%€84.88€83.781.65 million shs$0.0007/23/2025€82.30€82.55+0.30%€82.96€81.821.41 million shs$0.0007/22/2025€83.12€82.30-0.99%€83.20€82.141.26 million shs$0.0007/21/2025€83.12€83.12€83.80€82.981.24 million shs$0.0007/18/2025€83.20€83.54+0.41%€84.07€82.961.31 million shs$0.0007/17/2025€82.70€83.20+0.60%€84.05€83.001.37 million shs$0.0007/16/2025€83.54€82.70-1.01%€84.06€82.491.66 million shs$0.0007/15/2025€83.03€83.54+0.61%€83.71€82.87910,100 shs$0.0007/14/2025€83.03€83.03€84.13€82.762.13 million shs$0.0007/11/2025€83.32€84.16+1.01%€84.30€83.612.11 million shs$0.0007/10/2025€83.33€83.32-0.01%€83.59€82.031.87 million shs$0.0007/09/2025€82.44€83.33+1.08%€83.33€81.721.72 million shs$0.0007/08/2025€83.29€82.44-1.02%€83.17€81.941.32 million shs$0.0007/07/2025€83.29€83.29€83.82€82.031.12 million shs$0.00 Related Companies Compagnie Générale des Établissements Michelin Société en commandite par actions Stock Chart Deutsche Bank Aktiengesellschaft Stock Chart Bayer Aktiengesellschaft Stock Chart Fielmann Group Stock Chart Fresenius SE & Co. KGaA Stock Chart Genfit Stock Chart Sartorius Aktiengesellschaft Stock Chart Sartorius Stedim Biotech Stock Chart Siemens Healthineers Stock Chart Merck KGaA Stock Chart Receive SAN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter. This page (EPA:SAN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
